These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28161826)

  • 21. ADC Metrics From Multiparametric MRI: Histologic Downgrading of Gleason Score 9 or 10 Prostate Cancers Diagnosed at Nontargeted Transrectal Ultrasound-Guided Biopsy.
    Sadoughi N; Krishna S; McInnes MDF; Flood TA; Breau RH; Morash C; Schieda N
    AJR Am J Roentgenol; 2018 Sep; 211(3):W158-W165. PubMed ID: 29995495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
    Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
    AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diffusion-weighted imaging for prostate cancer localization: comparison of apparent diffusion coefficient values in cancerous and non-cancerous tissues, and the Gleason score of the radical prostatectomy specimens].
    Kobayashi H; Kitamura K; Mizukami S; Hanazawa K; Sakamoto Y
    Nihon Hinyokika Gakkai Zasshi; 2013 May; 104(3):489-95. PubMed ID: 23819360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
    Kim CK; Park BK; Kim B
    AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.
    Pepe P; D'Urso D; Garufi A; Priolo G; Pennisi M; Russo G; Sabini MG; Valastro LM; Galia A; Fraggetta F
    In Vivo; 2017; 31(3):415-418. PubMed ID: 28438871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.
    Rosenkrantz AB; Triolo MJ; Melamed J; Rusinek H; Taneja SS; Deng FM
    J Magn Reson Imaging; 2015 Mar; 41(3):708-14. PubMed ID: 24616064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer?
    Kitajima K; Takahashi S; Ueno Y; Miyake H; Fujisawa M; Kawakami F; Sugimura K
    Eur J Radiol; 2013 Aug; 82(8):1219-26. PubMed ID: 23518144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy.
    Verma S; Rajesh A; Morales H; Lemen L; Bills G; Delworth M; Gaitonde K; Ying J; Samartunga R; Lamba M
    AJR Am J Roentgenol; 2011 Feb; 196(2):374-81. PubMed ID: 21257890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced MR imaging for assessment of tumor aggressiveness in prostate cancer at 3T.
    Fukunaga T; Tamada T; Kanomata N; Takeuchi M; Ueda Y; Miyaji Y; Kido A; Yamamoto A; Sone T
    Magn Reson Imaging; 2021 Nov; 83():152-159. PubMed ID: 34454006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate MRI: evaluating tumor volume and apparent diffusion coefficient as surrogate biomarkers for predicting tumor Gleason score.
    Donati OF; Afaq A; Vargas HA; Mazaheri Y; Zheng J; Moskowitz CS; Hricak H; Akin O
    Clin Cancer Res; 2014 Jul; 20(14):3705-11. PubMed ID: 24850842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ratio of Tumor to Normal Prostate Tissue Apparent Diffusion Coefficient as a Method for Quantifying DWI of the Prostate.
    Barrett T; Priest AN; Lawrence EM; Goldman DA; Warren AY; Gnanapragasam VJ; Sala E; Gallagher FA
    AJR Am J Roentgenol; 2015 Dec; 205(6):W585-93. PubMed ID: 26587948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.
    Kido A; Tamada T; Sone T; Kanomata N; Miyaji Y; Yamamoto A; Ito K
    Radiol Med; 2017 Mar; 122(3):228-238. PubMed ID: 27943099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
    J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map.
    Shinmoto H; Tamura C; Soga S; Okamura T; Horiguchi A; Asano T; Kaji T
    AJR Am J Roentgenol; 2015 Aug; 205(2):W185-92. PubMed ID: 26204306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
    Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
    Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of the normalized apparent diffusion coefficient for preoperative evaluation of the aggressiveness of prostate cancer.
    Itatani R; Namimoto T; Yoshimura A; Katahira K; Noda S; Toyonari N; Kitani K; Hamada Y; Kitaoka M; Yamashita Y
    Jpn J Radiol; 2014 Dec; 32(12):685-91. PubMed ID: 25323833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers.
    Costa DN; Xi Y; Aziz M; Passoni N; Shakir N; Goldberg K; Francis F; Roehrborn CG; Leon AD; Pedrosa I
    AJR Am J Roentgenol; 2019 Jan; 212(1):109-116. PubMed ID: 30383404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?
    de Perrot T; Scheffler M; Boto J; Delattre BM; Combescure C; Pusztaszeri M; Tille JC; Iselin C; Vallée JP
    J Magn Reson Imaging; 2016 Sep; 44(3):601-9. PubMed ID: 26914964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI of the Prostate With and Without Endorectal Coil at 3 T: Correlation With Whole-Mount Histopathologic Gleason Score.
    Dhatt R; Choy S; Co SJ; Ischia J; Kozlowski P; Harris AC; Jones EC; Black PC; Goldenberg SL; Chang SD
    AJR Am J Roentgenol; 2020 Jul; 215(1):133-141. PubMed ID: 32160050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.